PODESTA GROUP, INC. for BRISTOL-MYERS SQUIBB

Medicare/Medicaid MMM

H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H. R. 3162, Children's Health and Medicare Protection Act of 2007 H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R. 1424, Emergency Economic Stabilization Act of 2008

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5480 (110th), S. 2029 (110th), H.R. 3162 (110th), S. 3 (110th), S. 2662 (110th), S. 1376 (110th), H.R. 4 (110th), H.R. 1424 (110th), H.R. 2606 (110th)

Pharmacy PHA

H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug importation H.R. 5629, Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1038 (110th), S. 623 (110th), S. 1695 (110th), S. 596 (110th), S. 1505 (110th), H.R. 1561 (110th), H.R. 5629 (110th), S. 2029 (110th), H.R. 5839 (110th), H.R. 1956 (110th)

Budget/Appropriations BUD

FY09 Administration Budget House Concurrent Resolution 312 FY09 Revised Congressional Budget Senate Concurrent Resolution 70 FY09 Congressional Budget Comparative Effectiveness FDA/drug importation issues

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS)

Medical/Disease Research/Clinical Labs MED

LHHS appropriations Diabetes research issues Comparative effectiveness

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill S. 3600, Patent Reform Act of 2008, entire bill

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1145 (110th), S. 3600 (110th), H.R. 1908 (110th)